ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,372Medicare Part D Prescriptions Filled, Including Refills

Rank: 617 out of 4623

$282K Total Retail Price of All Prescriptions

Rank: 1723 out of 4623

287 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,995 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$30 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 793 727 1 4
HYDROCHLOROTHIAZIDE 625 544 2 10
SIMVASTATIN 615 556 3 2
ATENOLOL 474 427 4 28
CLONIDINE HCL 430 350 5 40
AMLODIPINE BESYLATE 395 344 6 5
HYDRALAZINE HCL 363 336 7 99
METFORMIN HCL 282 243 8 6
CARVEDILOL 244 215 9 25
LEVOTHYROXINE SODIUM 240 198 10 1
GLYBURIDE 218 170 R 11 59
NIFEDIPINE ER 212 180 12 97
NIFEDIAC CC 207 188 13 309
METOPROLOL SUCCINATE 197 158 14 13
FUROSEMIDE 178 164 15 8
TRAMADOL HCL 168 126 16 15
HYDROCODONE-ACETAMINOPHEN 138 107 S3 17 3
TAMSULOSIN HCL 135 130 18 29
IBUPROFEN 128 101 19 65
GLIPIZIDE 95 89 20 49
METHYLPREDNISOLONE 89 74 21 103
CYCLOBENZAPRINE HCL 89 55 R 21 53
ALLOPURINOL 88 86 23 37
NEXIUM 84 61 24 17
FLUTICASONE PROPIONATE 84 73 24 32
GABAPENTIN 76 47 26 16
TRIAMTERENE-HYDROCHLOROTHIAZID 75 48 27 234
WARFARIN SODIUM 71 62 28 24
DOXEPIN HCL 67 55 29 209
OMEPRAZOLE 67 57 29 7
CLOPIDOGREL 67 60 29 31
CRESTOR 61 45 32 20
SERTRALINE HCL 59 36 33 26
DOXYCYCLINE HYCLATE 59 49 33 101
CIMETIDINE 56 49 35 530
METOPROLOL TARTRATE 56 56 35 9
PLAVIX 56 53 35 45
METOCLOPRAMIDE HCL 55 47 38 126
PANTOPRAZOLE SODIUM 54 42 39 35
AMOXICILLIN 51 40 40 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.